Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling

被引:0
作者
Bénédicte Rousseau
Sengottuvelan Murugan
Ajay Palagani
Dipak K. Sarkar
机构
[1] The State University of New Jersey,Endocrine Research Program, Department of Animal Sciences, Rutgers
来源
Breast Cancer Research | / 24卷
关键词
Triple-negative breast cancer; Growth and metastasis; Beta-adrenergic receptor; Mu-opioid receptor; GSK3 signaling; Gene knockdown; Pharmacological agents;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 303 条
[1]  
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30
[2]  
Miller KD(2010)Triple-negative breast cancer N Engl J Med 363 1938-1944
[3]  
Jemal A(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol Off J Am Soc Clin Oncol 26 1275-1281
[4]  
Foulkes WD(2009)Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer Clin Breast Cancer 9 S73-81
[5]  
Smith IE(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol Off J Am Soc Clin Oncol 30 1796-1804
[6]  
Reis-Filho JS(2018)Psychological stress and breast cancer incidence: a systematic review Clujul Med 91 18-26
[7]  
Liedtke C(1998)Depressive reactions to lung cancer are common and often followed by a poor outcome Eur Respir J 11 173-178
[8]  
Mazouni C(1999)Influence of psychological response on survival in breast cancer: a population-based cohort study Lancet Lond Engl 354 1331-1336
[9]  
Hess KR(2009)Depression as a predictor of disease progression and mortality in cancer patients Cancer 115 5349-5361
[10]  
André F(2015)Low β 2 -adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism Oncotarget 7 1878-1894